Immunovant IMVT
NASDAQ IMVT
$28.24 -0.35 (-1.22%)
As of: Oct 21, 2026 · 2:49 PM EDT

Immunovant (IMVT) EBIT Margin (2022 - 2026)

Updated

Analysis

Immunovant (IMVT) EBIT Margin (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,136.71 Bn 1,105.29 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.55 Bn 536.07 Bn 17.26 Bn 28.21%
3 AbbVie 501.02 Bn 474.13 Bn 12.70 Bn 37.86%
4 Merck 368.18 Bn 322.56 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.89 Bn 261.88 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn 20.57%
7 Amgen 236.60 Bn 191.99 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.55 Bn 164.75 Bn 6.22 Bn -133.21%
9 Pfizer 169.77 Bn 116.42 Bn 10.94 Bn 28.37%
10 Immunovant 5.81 Bn 2.59 Bn - -2,159.61%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,159.61%
Mar 31, 2026 -1,870.66%
Dec 31, 2025 -2,045.43%
Sep 30, 2025 -2,246.75%
Jun 30, 2025 -1,888.91%
Mar 31, 2025 -1,536.96%
Dec 31, 2024 -2,417.65%
Sep 30, 2024 -1,795.50%
Jun 30, 2024 -1,212.72%
Mar 31, 2024 -896.13%
Dec 31, 2023 -576.81%
Sep 30, 2023 -1,629.56%
Jun 30, 2023 -1,819.14%
Mar 31, 2023 -1,736.29%
Dec 31, 2022 -2,134.51%
Sep 30, 2022 -4,130.59%
API Access

Immunovant EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=IMVT&period=max&api_key=YOUR_API_KEY